MDPI and ACS Style
Assié, J.-B.; Crépin, F.; Grolleau, E.; Canellas, A.; Geier, M.; Grébert-Manuardi, A.; Akkache, N.; Renault, A.; Hauss, P.-A.; Sabatini, M.;
et al. Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers 2022, 14, 1498.
https://doi.org/10.3390/cancers14061498
AMA Style
Assié J-B, Crépin F, Grolleau E, Canellas A, Geier M, Grébert-Manuardi A, Akkache N, Renault A, Hauss P-A, Sabatini M,
et al. Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers. 2022; 14(6):1498.
https://doi.org/10.3390/cancers14061498
Chicago/Turabian Style
Assié, Jean-Baptiste, Florian Crépin, Emmanuel Grolleau, Anthony Canellas, Margaux Geier, Aude Grébert-Manuardi, Nabila Akkache, Aldo Renault, Pierre-Alexandre Hauss, Marielle Sabatini,
and et al. 2022. "Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study" Cancers 14, no. 6: 1498.
https://doi.org/10.3390/cancers14061498